Matthew Stafford, MBA
Proven commercial leader with 34 years of experience in biopharma and medtech, known for helping companies solve complex commercial challenges, scale revenue, and win in competitive markets. His expertise spans market access, go-to-market execution, enterprise account strategy, and building operating models that perform under pressure.
Matthew was a founding U.S. leader of Organon following its 2020 spin-off from Merck, where he helped build and lead the U.S. Biosimilars Business Unit. He later transitioned to lead the U.S. Market Access team, overseeing Group Purchasing Organizations, National Health Systems, Federal/DoD channels, and U.S. distribution partners.
Across his career, Matthew has earned a reputation as the leader you deploy when the stakes are high and the path is unclear. He builds trust quickly, forges strong cross-functional partnerships, and inspires teams to deliver exceptional results. In 2026, Matthew launched a new venture as the founding leader of GTM and its first Strategic Advisor focused on Healthcare, Biopharma and MedTech.
Discover how Matthew can help your business move faster and further.
James W. Fee, Jr
Jim brings more than 40 years of executive and financial leadership across multiple industries. He has a proven history of successfully managing financial and business results, and as CEO of a privately held holding company, led the growth of operations across multiple locations. His expertise in acquisitions, integration, strategic planning, and team development has consistently delivered successful outcomes for all stakeholders.
He has extensive experience leading complex financial transactions in private equity, for large and middle market corporations, and as an investment banker. He has been responsible for the origination, structuring, negotiation, and integration of numerous successful transactions valued at more than $40 billion — spanning public and private debt, mezzanine and equity capital placements, mergers and acquisitions, shareholder value enhancements, and strategic planning initiatives.
He has founded and directed two new successful business units and brings significant sector depth in food, agribusiness, telecommunications, and financial services. Jim served six years on active duty as an Officer in the United States Navy, where he was designated a naval aviator.
Discover how Jim can help your business move faster and further.
Matthew Stafford, MBA
Proven commercial leader with 34 years of experience in biopharma and medtech, known for helping companies solve complex commercial challenges, scale revenue, and win in competitive markets. His expertise spans market access, go-to-market execution, enterprise account strategy, and building operating models that perform under pressure.
Matthew was a founding U.S. leader of Organon following its 2020 spin-off from Merck, where he helped build and lead the U.S. Biosimilars Business Unit. He later transitioned to lead the U.S. Market Access team, overseeing Group Purchasing Organizations, National Health Systems, Federal/DoD channels, and U.S. distribution partners.
Across his career, Matthew has earned a reputation as the leader you deploy when the stakes are high and the path is unclear. He builds trust quickly, forges strong cross-functional partnerships, and inspires teams to deliver exceptional results. In 2026, Matthew launched a new venture as the founding leader of GTM and its first Strategic Advisor focused on Healthcare, Biopharma and MedTech.
Discover how Matthew can help your business move faster and further.
James W. Fee, Jr
Jim brings more than 40 years of executive and financial leadership across multiple industries. He has a proven history of successfully managing financial and business results, and as CEO of a privately held holding company, led the growth of operations across multiple locations. His expertise in acquisitions, integration, strategic planning, and team development has consistently delivered successful outcomes for all stakeholders.
He has extensive experience leading complex financial transactions in private equity, for large and middle market corporations, and as an investment banker. He has been responsible for the origination, structuring, negotiation, and integration of numerous successful transactions valued at more than $40 billion, spanning public and private debt, mezzanine and equity capital placements, mergers and acquisitions, shareholder value enhancements, and strategic planning initiatives.
He has founded and directed two new successful business units and brings significant sector depth in food, agribusiness, telecommunications, and financial services. Jim served six years on active duty as an Officer in the United States Navy, where he was designated a naval aviator.
Discover how Jim can help your business move faster and further.